• Google announces $1 billion job training and education program

    Here are the key components of Google's effort:

    -- The U.S. Grow with Google initiative will allow communities to access training and other resources from Google. A multi-city tour to kick off the effort will start Nov. 10 in Indianapolis.

    -- The partnership with Goodwill aims to have 1,000 Google employees training 1.2 million people in digital skills and job opportunities over the next three years.

    -- The global effort will provide $1 billion in grants to nonprofits around the world. Google is pledging 1 million employee volunteer hours as well.

    Read More
  • NBC 29's Coverage of Tech Tour 2017

    Charlottesville Business Innovation Council Hosts 'Tech Tour' for Students

    CHARLOTTESVILLE, Va. (WVIR) -
    Hundreds of students in central Virginia got to step into their futures Tuesday as part of an event from Charlottesville Business Innovation Council.

    Read More
  • October 18 Briefing in Cville on Grant Funding from CRCF

    Seeking Technology Commercialization Funding? Join an October 18 briefing by CIT on the FY18 RFP for the Commonwealth Research Commercialization Fund (CRCF). This multi-million dollar grant program supports technology commercialization projects in Virginia. UVA and Charlottesville-based companies have been major funding recipients in the past! RSVP here and get more details about the session here

    Read More
  • CIT GAP Funds and Charlottesville Angel Network Invests in Advanced Aircraft Company

    Source:  Center for Innovative Technology

    Herndon, Virginia, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The Center for Innovative Technology (CIT) announced today that its CIT GAP Funds has invested in Advanced Aircraft Company (AAC), an aeronautical engineering and aircraft manufacturing company based in Hampton Roads, Virginia. The Charlottesville Angel Network also participated in this investment round alongside CIT.

    The Advanced Aircraft Company specializes in vertical takeoff and landing unmanned aerial systems, that target both the commercial and military markets.  AAC was founded by William J. Fredericks in October 2015 as a technology spin off from the NASA Langley Research Center.  While employed at NASA, Fredericks performed the conceptual design and lead the development of NASA’s Greased Lightning UAV technology. This technology is unique in that it is a true “no compromises” vertical takeoff and landing (VTOL) aircraft.  It achieves the aerodynamic efficiency of a conventional fixed wing airplane, while simultaneously achieving VTOL capability. AAC has developed a licensing agreement that allows the company to utilize the NASA technology in order to bring it to market.

    In addition to the Greased Lightning, AAC has developed another cutting edge aircraft, which it will bring to market first, the Hercules unmanned aircraft system (UAS). The Hercules is a multi-rotor UAS powered by electricity generated by a 2-stroke gasoline engine and features number of aerodynamic improvements. The unique aircraft features a streamlined aerodynamic design, which features hybrid electric propulsion that allows for longer flight times, and rigorous safety procedures that can be employed if the combustion engine fails.  These technologies enable the Hercules UAS to fly multiple hours, while other battery powered multi-rotors are limited to 20 to 30 minutes of flight time. 

    Read full article at Globe Newswire

    Read More
  • AgroSpheres announces close of oversubscribed $750,000 seed round

    CHARLOTTESVILLE, Virginia – AgroSpheres announces the successful close of an oversubscribed seed round of $750,000 from local and international angel investors. AgroSpheres is a biotechnology company developing novel nanotechnologies aiming to set a new standard for bio-based delivery of active ingredients. The funding will be used to broaden utility of the platform, build a strong intellectual property portfolio, and outfit the company’s facilities.
     
    AgroSpheres has made significant breakthroughs in the effective and precise delivery of high-value biomolecules and chemicals to a wide range of intended targets. Using next-generation bioengineering and industrial fermentation allow AgroSpheres to out scale competitors at a lower cost.
     
    The platform’s focal point is a nanoscale bioparticle created from environmentally friendly microbes that can be functionalized by immobilizing and/or encapsulating active ingredients. Although the applicability of the platform is extremely versatile, the company is focused on developing their technology to innovate the fields of agriculture and industrial enzymes.
     
     “We are excited to be developing our technology for precision agriculture applications - we want to help farmers maximize their yields while minimizing their exposure to dangerous chemicals and the off-target exposure of agrochemicals to the environment,” said Payam Pourtaheri, Co-Founder.
     
    Ameer Shakeel, Co-Founder, said, “It is opportune timing for us to be making a cost-effective delivery vehicle for enzymes. We see growing value in using industrial enzymes as environmentally friendly, efficient alternatives to synthetic chemicals in various manufacturing industries.”
     
    Prior to this round of funding, the company was funded by $174,000 from grants and awards from competitions, most notably Thought for Food, The Collegiate Inventor’s Competition, VentureWell, and the Virginia Wine Board.  The company continues to receive strong support from the Charlottesville community and the University of Virginia, including the iLab incubator program.
     
    “The founders of AgroSpheres have created a groundbreaking nano-delivery technology by working across disciplines and leveraging multiple departments at the University of Virginia. The AgroSpheres Interdisciplinary Model has set a new standard for translational research and development,” said Dr. Mark Kester, Co-Founder.

    Read More
  • Cavion Appoints Spyridon Papapetropoulos, M.D., Ph.D. as Executive Vice President, Research and Development and Chief Medical Officer

    CHARLOTTESVILLE, Va.--()--Cavion, Inc., a clinical stage biopharmaceutical company, announced today that Dr. Spyridon "Spyros" Papapetropoulos has joined as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Papapetropoulos will lead Cavion’s research and development organization to advance therapies based on the company’s T-type calcium channel (Cav3) platform.

    “Spyros joins the Cavion team at an exciting time. He is an experienced leader with a passion for conducting innovative trials that deliver new treatment options to patients with neurological diseases with limited treatment options,” said Cavion CEO and President Andrew Krouse. He added, “Spyros will help extend Cavion’s presence in the Boston/Cambridge area.”

    Dr. Papapetropoulos noted, “Cavion’s selective Cav3 modulating platform, which includes best-in-class clinical stage compounds, is expected to restore rhythmic neuronal firing in brain regions associated with a variety of chronic neurological diseases.” He added, “I look forward to working closely with Cavion’s team to apply innovative but empathetic approaches to achieving clinical breakthroughs. Our end goal is to bring safe, effective and accessible treatments to people with chronic neurological diseases, quickly and efficiently.”

    For full article, visit Business Wire

    Read More
  • Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems

    GERMANTOWN, Md.--(BUSINESS WIRE)--

    Senseonics Holdings, Inc. (SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and TypeZero Technologies, Inc., a personalized diabetes management company, today announced the signing of a research and development license agreement to develop artificial pancreas and decision support systems that use the Eversense CGM System.

    The goal of the agreement is to integrate glucose readings from the Eversense CGM System into TypeZero’s inControl software platform, which includes decision support and artificial pancreas system solutions. Combined with insulin data, the continuous glucose readings from the Eversense sensor will equip TypeZero’s artificial pancreas algorithms to automatically adjust and regulate insulin delivery via a user’s insulin pump. The integration will also enable TypeZero’s decision support system to recommend optimal basal and bolus doses for insulin pen users.

    “We’re thrilled to partner with TypeZero with the goal of progressing the diabetes management field in providing solutions to help minimize the burden of diabetes for millions of people,” says Tim Goodnow, President and CEO of Senseonics. “It is particularly gratifying that the combined Eversense and inControl platform is intended to be used by either insulin pumpers or insulin pen users. The continuous long-term use of an accurate sensor such as Eversense combined with the clinically proven treatment algorithms of inControl has the promise of impacting both pump and pen users in a positive and meaningful way.”

    For full article, visit Yahoo Finance

    Read More
  • Diffusion Pharmaceuticals Selects Contract Research Organization for Phase 3 Clinical Trial of Lead Compound TSC for Inoperable GBM Brain Cancer

    Company Release - 7/31/2017 8:30 AM ET

    CHARLOTTESVILLE, Va., July 31, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN), a clinical stage biotechnology company developing novel small molecule therapeutics for cancer and other hypoxia-related diseases, announced today that it has selected a premier Clinical Research Organization (CRO) to conduct a Phase 3 clinical trial of Diffusion's lead molecule, trans sodium crocetinate (TSC), in inoperable glioblastoma multiforme (GBM) patients.  Diffusion also entered into agreements with top tier partners to manage the MRI imaging, clinical data management, drug supply and other functions related to the trial. Diffusion plans to initiate this Phase 3 clinical trial by the end of 2017.

    “After reaching the critical milestone of manufacturing drug product for our Phase 3 trial earlier this month, we have now reached another major milestone with the selection of our full clinical trial team, including a leading global CRO and first-in-class providers of imaging and data management services,” said David Kalergis, Diffusion’s Chairman and CEO. “We are pleased to have engaged such skilled and experienced partners for this important endeavor.”

    Diffusion is now interacting with the FDA on details regarding the design and execution of the planned Phase 3 study. The study will focus on treating newly diagnosed GBM patients who have been judged by their medical team to be inoperable, usually because of the size or location of the tumor. Due to their poor prognosis, these patients are often excluded from participation in other GBM clinical trials. In the Company’s Phase 2 GBM trial, the TSC-treated inoperable group showed a nearly four-fold increase in survival at two years, compared to the control.

    For full article, visit Diffusion Pharmaceuticals 

    Read More
  • Biovista expands Project Prodigy collaborations in personalized medicine

    Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings.

    Biovista announced today that it is collaborating with HPE to advance Biovista's Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. Advances from the HPE-Biovista collaboration will be used initially within the context of Biovista's existing collaboration with Sarah Bush Lincoln Health Center (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year.

    ...read more at PR Newswire

    Read More
  • VividCortex Raises $8.5m

    VividCortex, the database performance management company that helps businesses improve application performance, reliability, and uptime, today announced that it has closed an $8.5 million Series A-1 round led by Osage Venture Partners (OVP). Bull City Venture Partners also participated in the round, as did all existing investors, including New Enterprise Associates (NEA) and Battery Ventures. As part of the financing, OVP Partner David Drahms has been appointed to the VividCortex Board of Directors. To date, VividCortex has raised $15 million.

    ...

    Read more at prweb

    Read More
  • Kim Wilkens RE: Technology's Bro Culture

    Kim Wilkens (aka TechKim) is passionate about transforming technology users into technology creators, collaborators & activists and proud to do this work with many collaborators and partners including Mozilla Network50, CS Educator @ St. Anne’s-Belfield School, Tech-Girls founder, Charlottesville Women in Tech outreach and CBIC Tech Tour chair. 

    Check out her podcast on technology's bro culture here!

    Read More
  • City’s Open Data Portal Nears Launch

    July 2, 2017

    Tech-oriented and data-savvy folks soon will have the chance to dive deep into a new Charlottesville portal that will disclose public information about policing, property, traffic, parks, demographics and the environment.

    The launch of the city’s open data portal later this summer is part of an initiative that started last year to make the city government more transparent and encourage the growth of the city’s tech industry.

    “This is a really cool project,” Mayor Mike Signer said moments before the council unanimously adopted an official open data policy last month. “This will put us at the leading edge of governments doing this kind of thing.”

    Read Full Story From The Daily Progress

    Read More
  • Program Showcases Charlottesville’s Makers, Products

    A new initiative is promoting candy, furniture and software under a single brand: Made in Charlottesville.

    The program, sponsored by the city’s Office of Economic Development, aims to increase the visibility of businesses that design or manufacture products within the city limits.

    “There are many businesses in Charlottesville that are really well known nationally — even internationally — that no one knows about here,” said Jason Ness, business development manager for the city.

    Ness cited as examples Blanc Creatives, whose hand-forged cookware won the top prize in Garden & Gun magazine’s Made in the South Awards for 2015; and Rockbridge Guitar, which makes instruments for some of the world’s premier rock and folk musicians.

    Although these two businesses have a limited customer base in Charlottesville, Ness said they benefit the community by creating jobs and inspiring civic pride “... in knowing that these things were manufactured or made here.”

    Read Full Story From Cville Tomorrow

    Read More
  • MACH37 Cyber Accelerator Opens Applications for Fall 2017 Session

    Fall 2017 Cohort Session to Begin on September 5th

    July 11, 2017 (HERNDON, Va.) – The MACH37 Cyber Accelerator has officially announced it will begin accepting applications from information security product startups and security entrepreneurs for its Fall 2017 (F17) Cohort that begins on September 5th. The MACH37 program consists of an intense 90-day program in which the selected startups are coached in all aspects of creating a successful and sustainable business.

    Read More
  • New Cville Office Space

    First, he brought you Studio IX, and now he’s set his sights on another collaborative workspace, one for whom he dubs the town’s creative entrepreneurs.

    In the Downtown Mall’s historic Bradbury building—the former Bank of America space—James Barton prepares to open Vault Virginia, where he says commercial atmosphere will meet a residential one in a number of “warm, inviting, art-infused and culturally refined” office spaces.

    Read Full Story from c-ville

    Read More
  • 1 Google announces $1 billion job training and education program
  • 2 NBC 29's Coverage of Tech Tour 2017
  • 3 October 18 Briefing in Cville on Grant Funding from CRCF
  • 4 CIT GAP Funds and Charlottesville Angel Network Invests in Advanced Aircraft Company
  • 5 AgroSpheres announces close of oversubscribed $750,000 seed round
  • 6 Cavion Appoints Spyridon Papapetropoulos, M.D., Ph.D. as Executive Vice President, Research and Development and Chief Medical Officer
  • 7 Senseonics and TypeZero Sign Development Agreement for Artificial Pancreas and Decision Support Systems
  • 8 Diffusion Pharmaceuticals Selects Contract Research Organization for Phase 3 Clinical Trial of Lead Compound TSC for Inoperable GBM Brain Cancer
  • 9 Biovista expands Project Prodigy collaborations in personalized medicine
  • 10 VividCortex Raises $8.5m
  • 11 Kim Wilkens RE: Technology's Bro Culture
  • 12 City’s Open Data Portal Nears Launch
  • 13 Program Showcases Charlottesville’s Makers, Products
  • 14 MACH37 Cyber Accelerator Opens Applications for Fall 2017 Session
  • 15 New Cville Office Space
  • Holiday Banner

    Annual CBIC and VABIO Holiday Party
    Tuesday, Dec. 12, 2017; 5 - 8pm

     

    Read more

News

Recurring Events

  • CBIC Awards

    CBIC Awards

    The Charlottesville area is recognized for its exceptional high-tech community and entrepreneurial spirit. CBIC is proud to spotlight leadership in these areas annually through the highly anticipated CBIC Awards.
    Read More
  • Tech Tour

    Tech Tour

    CBIC's annual Tech Tour is all about igniting local students' interest in technology-related careers and showing the variety of opportunities available in our community to pursue their passions.
    Read More
  • TechOnTap

    TechOnTap

    This monthly event provides an opportunity for tech-minded people to network in a happy hour setting.
    Read More

Blog Posts

  • All
  • Infrastructure
  • Investment
  • Leadership
  • Marketing
  • Resource
  • Startups
  • STEM
  • Tech Tour
load more hold SHIFT key to load all load all

Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics to advance real-world personalized medicine at community hospital settings.

Biovista announced today that it is collaborating with HPE to advance Biovista's Project Prodigy Big Data AI healthcare platform applied in the personalized medicine vertical. Advances from the HPE-Biovista collaboration will be used initially within the context of Biovista's existing collaboration with Sarah Bush Lincoln Health Center (SBL), a hospital and health care organization that is home to more than 300,000 provider office visits per year.

...read more at PR Newswire

ABOUT THE AUTHOR
Author: India Brahm

Annual Partners

  • WillowTree
  • Gardy Bloemers
  • Batten Institute
  • CoshXLabs
  •  Blue Ridge Bank
  •  City of Charlottesville
  • Center for Innovative Technology

@CBICouncil

Cville Tech Calendar

From Cville Tomorrow

Local tech firm helping Charlottesville Works Initiative scale up services

Nov 17, 2017

In celebration of its 10th anniversary, the Center for Nonprofit Excellence has partnered with local media outlets to create ParadigmShifters, a series of interviews with leaders— particularly new leaders— who are working to make our community stronger. Rachel...

Read more

Local wound-care startup continues to impress

Nov 08, 2017

InMEDBio, one of the University of Virginia’s most successful undergraduate startups, added to its momentum recently with a bronze medal at the national Collegiate Inventors Competition. Founded by fourth-year student Ashwinraj Karthikeyan, InMEDBio’s first product, Phoenix-Aid...

Read more

UVA student brings ancient Incan designs to Charlottesville and beyond

Oct 28, 2017

University of Virginia student Kris Cody has put his undergraduate career on hold to distribute handmade Peruvian alpaca wool sweaters around the world. As Cody sees it, these sweaters bridge a gap between communities like Charlottesville...

Read more

Local entrepreneurs bring farming indoors

Oct 19, 2017

Two local entrepreneurs are seeking to revolutionize farming, reduce energy expenditures and increase productivity by bringing their crop-growing indoors. Beanstalk Farms is a Charlottesville-based agricultural technology company that produces scalable, automated and sustainable vertical farms. Its innovative...

Read more

HemoShear Therapeutics partnering with global drugmaker to treat liver disease

Oct 17, 2017

Charlottesville biotechnology company HemoShear Therapeutics could receive over $470 million from a new partnership with Takeda Pharmaceutical Company, Asia’s largest pharmaceutical firm. Takeda, headquartered in Japan, will have exclusive access to HemoShear’s proprietary platform for modeling...

Read more

Super-social: Moran leaving digital legacy of 103,000-plus tweets

Oct 15, 2017

Retiring Albemarle schools superintendent building thriving online community for educators In her first tweet, Pam Moran told her followers that she was “... thinking about simplicity, creativity and -12 education.” Those are topics the Albemarle County...

Read more